MECP2 mutations rewire human ESC fate and bias cortical lineage commitment
Stem Cell Reports · 2026
DOI: 10.1016/j.stemcr.2026.102895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2026. Verfasst von Marion Guillon und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre de recherche Azrieli du CHU Sainte-Justine, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, Mutation, Cell Lineage, Human Embryonic Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stem Cell Network, Canadian Institutes of Health Research, Brain Canada Foundation.
Abstract (Originalsprache)
Rett syndrome arises from loss-of-function mutations in the X-linked chromatin regulator MECP2, yet the earliest molecular derailments in development are poorly defined. Using isogenic human embryonic stem cell (hESC) models carrying three patient-derived MECP2 mutations, we followed the transcriptome from pluripotency through neuroectoderm, neural stem/progenitor stages. Developmental stage dominated transcriptional variance, but mutants shared a secondary program enriched for synaptic-membrane and extracellular matrix genes. Single-cell/bulk profiling at the embryonic stem cell (ESC) stage revealed partial naïve-like drift, marked by the up-regulation of the naïve-enriched factor ZFP42/REX1 and related markers in MECP2-mutant lines. Among convergently dysregulated genes, the cortical determinant EMX1 showed an abnormal developmental trajectory, early repression followed by overshoot, and was consistently altered across independent Rett PSC models. Single-nucleus RNA-seq of cerebral organoids uncovered allele-specific yet convergent disturbances in cortical lineage allocation. These data chart a continuous developmental trajectory for MECP2-mutant cells and nominate naïve-like drift and mis-timed EMX1 expression as tractable entry points for dissecting Rett pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de recherche Azrieli du CHU Sainte-Justine, Montreal, QC, Canada.
- Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
- Centre de recherche Azrieli du CHU Sainte-Justine, Montreal, QC, Canada; Department of Neurosciences, Université de Montréal, Montreal, QC, Canada. Electronic address: anthony.flamier@umontreal.ca.
Förderung
- Stem Cell Network
- Canadian Institutes of Health Research
- Brain Canada Foundation
Zitieren
APA
Guillon, M., Brin, M., Gabet, E., Gromaire, J., Bernard, M., Laurent, L., Rabin, T., Bianchin, L., Veziano, M., Kloda, J., Bernard, A., Asali, L., Liu, Y., & Flamier, A. (2026). MECP2 mutations rewire human ESC fate and bias cortical lineage commitment. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.102895
Vancouver
Guillon M, Brin M, Gabet E, Gromaire J, Bernard M, Laurent L, et al. MECP2 mutations rewire human ESC fate and bias cortical lineage commitment. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.102895
BibTeX
@article{Guillon2026,
author = {Guillon, Marion and Brin, Margaux and Gabet, Elodie and Gromaire, Justine and Bernard, Mathéa and Laurent, Laetitia and Rabin, Théo and Bianchin, Lisa and Veziano, Marie and Kloda, Julie and Bernard, Alexia and Asali, Laila and Liu, Yi and Flamier, Anthony},
title = {MECP2 mutations rewire human ESC fate and bias cortical lineage commitment},
journal = {Stem Cell Reports},
year = {2026},
doi = {10.1016/j.stemcr.2026.102895}
}
EUVIMED